MRCY · Mercury Systems Inc · Stock research

All prices and levels below are market observations, stated as analysis.

MRCY — Mercury Systems, Inc.

Current Thesis

The break condition carried in the prior note resolved to the downside and then extended. After the weekly close of $91.36 on 2026-08-21, price fell again to $89.59 on 2026-08-24 — a fourth consecutive decline from the post-print $111.12 close of 2026-08-14, and a close beneath the $90.17 of 2026-07-29 that had marked the summer floor. RSI(14) reads 20.3, a three-month price change of -9.8%, and 29.0% below the 52-week high of $126.21.

The leg still available to buy is contractual, not directional: $996.0M of the $1.9B+ backlog converts inside twelve months (FY26 10-K, filed 2026-08-18) against an FY27 revenue outline approaching $1.1B. Every published post-print target sits far above spot — the consensus is $114.33 across 10 analysts (stockanalysis.com, 2026-08-24), the lowest published post-print number Jefferies' $115 Hold. Six raises landed between 2026-08-19 and 2026-08-20 and price closed lower through all of them; Baird maintained Buy at $130 on 2026-08-24 into a lower close still.

The gap between an untouched target panel and a tape making lower closes is the whole question here. Nothing dated resolves it before the Q1 FY27 report, estimated ~2026-11-03 and not company-confirmed as of 2026-08-24.

The narrative is saturated. Dating it: the 2026-08-18 print and 10-K removed the binary; the coverage cluster ran 2026-08-19 (two Benzinga analyst-forecast roundups) through 2026-08-22 (Bulls and Bears) to a backward-looking "$1,000 invested 20 years ago" retrospective on 2026-08-24 — the shape of coverage that arrives after a move, not before one. Counter-evidence stays on the record: record bookings, a 38.4% backlog build, and a target panel entirely above the last close. A weekly close back above $111.12 would re-date the label to maturing.

Bullish and bearish views on Mercury Systems Inc

The model's bull view on Mercury Systems Inc (MRCY), in brief: Q4 FY26 bookings $660M, +93.1% YoY, book-to-bill 2.28 (release, 2026-08-18), closing an FY26 sequence of 1.23 / 1.48 / 2.28 and an FY26 book-to-bill of 1.57 on $1.5B of orders. The bear view: Adjusted EPS $0.37 missed the $0.38 consensus (2026-08-18); the shares were marked down 10.6% in the 2026-08-19 pre-market (Benzinga). Both cases follow in full.

Bull Case

• Q4 FY26 bookings $660M, +93.1% YoY, book-to-bill 2.28 (release, 2026-08-18), closing an FY26 sequence of 1.23 / 1.48 / 2.28 and an FY26 book-to-bill of 1.57 on $1.5B of orders.
• Backlog over $1.9B, +38.4% YoY; $996.0M scheduled to convert within twelve months (FY26 10-K, 2026-08-18). Most of an approaching-$1.1B FY27 frame is contracted before the year starts.
• Q4 revenue $289.782M against $266.403M consensus (Benzinga, 2026-08-18); FY26 revenue $983.6M vs $912.0M, adjusted EBITDA $150.2M vs $119.4M, adjusted EPS $1.06 vs $0.64.
• The cash turn printed: Q4 operating cash flow $42M and free cash flow $29M, after Q3 free cash flow of -$2M; FY26 $102M and $68M.
• Palantir strategic agreement, 2026-08-03, sponsored under the US government's Tradewind Prototype Agreement, applying Foundry to material planning and factory operations — a dated response to the production-capacity and single-source-supplier risk factors named in the FY26 10-K.
• The sell-side panel did not blink after the miss: RBC $105→$120, Baird $120→$130, Truist $109→$120, Piper Sandler $131, Jefferies $115 Hold (all 2026-08-19), Canaccord $106→$128 (2026-08-20), Baird reiterated $130 (2026-08-24). Rating split at 2026-08-24: 5 Strong Buy, 2 Buy, 2 Hold, 1 Strong Sell (stockanalysis.com).

Bear Case

• Adjusted EPS $0.37 missed the $0.38 consensus (2026-08-18); the shares were marked down 10.6% in the 2026-08-19 pre-market (Benzinga).
• Gross margin fell in the record quarter: 30.5% in Q4 FY26 versus 31.0% a year earlier, attributed to program mix and net EAC changes.
• FY26 closed with a GAAP net loss of $29.7M, -$0.50 per diluted share, leaving no trailing-earnings anchor beneath the multiple.
• The management frame is below the company's own long-term targets: adjusted EBITDA approaching $200M (high-teens margin) against a stated low-to-mid-20s goal, and free-cash-flow conversion approaching 35% against 50%.
• Insider flow ran one way into the decline. A Form 4 records CEO William L. the filing describes tax withholding on vested equity awards. Aggregate executive sales in the window total roughly $4.7M, with no insider purchases reported (MarketBeat compilation of SEC filings, 2026-08-21).
• The compensation plan's own metrics did not pay: a Form 4 dated 2026-08-14 records EVP Steven Ratner returning 2,695 performance shares to the issuer at $0.00, forfeited for below-target performance.

Setup & Price Structure

The closing sequence since the print is unambiguous: $111.12 (08-14) → $101.25 (08-19) → $94.23 (08-20) → $91.36 (08-21) → $89.59 (08-24). Four consecutive lower closes; no inside day, no reclaim attempt on the record so far.

The $89–90 area is the third dated touch of the same zone: a director's open-market sale printed at $89.361 on 2026-05-12, the post-FOMC session of 2026-07-29 closed $90.17 after a 9.27% single-day fall, and 2026-08-24 closed $89.59. This is the first of the three that sits below the prior two on a closing.

RSI(14) at 20.3 is the most stretched reading in the covered window (it was 33.7 on 2026-08-21). An oversold oscillator describes momentum exhaustion; it is not evidence of a floor. A base requires closes that stop making lows, and none exist yet.

Positioning observables, stated as observables:

• Last published short interest: 8.65% of float, 6.12 days to cover. The publication estimated for ~2026-08-26 is the first reading spanning the run to $111.12 and the reversal.
• Sell-side target dispersion is wide and panel-dependent: $114.33 across 10 analysts (stockanalysis.com, 2026-08-24) versus lower medians on wider aggregator panels. Any citation needs its panel named.
• 13F-sourced ownership headlines (a BlackRock position addition reported 2026-08-22) describe a quarter-end date up to 45 days before the filing appears and say nothing about current holdings.
• Market capitalisation stood at $5.39B on 2026-08-24 (stockanalysis.com).

Catalyst Calendar (next 30 days)

• ~2026-08-26 (est.) — FINRA short-interest publication for the 2026-08-14 settlement date. First reading covering the advance to $111.12 and the reversal that followed.
• ~2026-09-10 (est.) — FINRA short-interest publication for the end-August settlement date. Shows whether shorts pressed into the four-session decline or covered it.
• 2026-09-30 (just beyond the 30-day window) — end of the US federal fiscal year; FY2027 appropriations or continuing-resolution deadline. With roughly 97% of FY26 revenue tied to US and allied defense, funding continuity governs award and delivery timing for the $996.0M of twelve-month backlog.
• ~2026-11-03 (est.) — Q1 FY27 results, seasonally the lowest revenue quarter of the FY27 frame. No company-confirmed date published as of 2026-08-24.

Between 2026-08-25 and the November report there is no dated company event on the calendar. Anything that moves the shares inside that gap is flow, sector beta or an unscheduled award.

What Would Change Our Mind

The cleanest upside re-dating would be a weekly close back above $111.12, the last pre-reversal close of 2026-08-14; that would put the saturated label back to maturing and show the six raises finally recruiting a bid. Short of that, a first higher weekly close that holds the $89–90 zone would at least mark the start of a base, which does not exist today.

On the downside, a weekly close below $86 breaks the $89–90 zone that has absorbed selling since mid-May and removes the last dated closing reference beneath the July shelf.

Fundamentally, three observables would end the FY27 conversion argument: a Q1 FY27 book-to-bill under 1.0 after 2.28, closing backlog below the $1.9B reported 2026-08-18, or gross margin printing below 30.5% with management again citing net EAC changes and program mix. On positioning, Form 4 sales coded as discretionary open-market disposals — rather than the sell-to-cover coding on the 2026-08-20 CEO sale — filed between 2026-08-25 and 2026-09-30 with no offsetting purchases would say insiders are distributing rather than settling tax.

The reverse also holds: an unscheduled award announcement large enough to move the $996.0M twelve-month conversion figure, or a target cut from any of the six raisers, would each be a genuine change to the record rather than tape noise.

Correlation Notes

• Customer concentration is the dominant single-name risk factor: RTX 15%, Lockheed Martin 11%, Northrop Grumman 10% of FY26 revenue per the FY26 10-K — 36% across three primes. Their program-spend commentary transmits directly.
• Rate and risk-off sensitivity is measured, not assumed: the shares fell 9.27% to close $90.17 on 2026-07-29, the session the FOMC held at 3.50%–3.75%. With an FY26 GAAP net loss, there is no trailing-earnings support under a multiple compression.
• Defense-electronics complex: KTOS and AVAV trade the same narrative flow; their July lows are the reference for whether this is a single-name break or a sector one.
• Appropriations beta: ~97% of FY26 revenue is US and allied defense, so a continuing resolution around 2026-09-30 affects award timing across the group rather than Mercury alone.
• Palantir/Foundry adjacency: the 2026-08-03 agreement ties part of the operational-improvement story to a separate narrative complex with its own flow dynamics.